Clinical Trial Update: Salivary Extracellular Vesicle Associated lncRNAs in Heart Failure (SEAL-HF)

View source ↗

Summary

The SEAL-HF trial (NCT06169540) at Massachusetts General Hospital is evaluating salivary extracellular vesicle associated lncRNAs as biomarkers in heart failure…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Decompensated Heart Failure
• Heart Failure

Snippet

Sponsor: Massachusetts General Hospital | Conditions: CHF, ADHF | Status: RECRUITING